BioLineRx Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2024 | 1 | -$0.06 | -$0.02 | -$0.04 |
| Q4 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
BioLineRx Ltd. Earnings Date And Information
BioLineRx Ltd. last posted its earnings results on Thursday, August 15th, 2024. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.14 by $0.15. The company had revenue of 5.39 M for the quarter and had revenue of 4.80 M for the year. BioLineRx Ltd. has generated $-1 earnings per share over the last year ($-0.94 diluted earnings per share) and currently has a price-to-earnings ratio of -1.13. BioLineRx Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based on prior year's report dates.
BioLineRx Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q2 2024 | $0.01 | $3.93 M | $5.39 M | ||
| 03/26/2024 | Q1 2024 | -$0.22 | -$0.01 | 0.21 | $6.86 M | |
| 03/26/2024 | Q4 2023 | -$0.22 | -$0.19 | 0.03 | $4.80 M | |
| 09/29/2023 | Q3 2023 | -$0.26 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.30 | $0 | |||
| 03/22/2023 | Q1 2023 | -$0.14 | -$0.25 | -0.11 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.14 | -$0.05 | 0.09 | $0 | |
| 09/29/2022 | Q3 2022 | -$0.13 | $0 | |||
| 05/11/2022 | Q2 2022 | -$0.15 | -$0.15 | 0 | $0 | |
| 03/16/2022 | Q1 2022 | -$0.14 | -$0.08 | 0.06 | $0 | |
| 11/18/2021 | Q4 2021 | -$0.13 | -$0.04 | 0.09 | $0 | |
| 11/18/2021 | Q3 2021 | -$0.13 | -$0.12 | 0.01 | $0 | |
| 05/26/2021 | Q2 2021 | -$0.15 | -$0.15 | 0 | $0 | |
| 02/23/2021 | Q1 2021 | -$0.25 | -$0.27 | -0.02 | $0 | |
| 02/23/2021 | Q4 2020 | -$0.25 | -$0.61 | -0.36 | $0 | |
| 09/29/2020 | Q3 2020 | -$0.23 | $0 | |||
| 05/20/2020 | Q2 2020 | -$0.83 | -$0.46 | 0.37 | $0 | |
| 03/12/2020 | Q1 2020 | -$0.64 | -$0.56 | 0.08 | $0 | |
| 11/12/2019 | Q4 2019 | -$0.99 | $0 | |||
| 11/12/2019 | Q3 2019 | -$0.40 | $100,000 | $0 |
BioLineRx Ltd. Earnings: Frequently Asked Questions
-
When is BioLineRx Ltd.'s earnings date?
BioLineRx Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based off last year's report dates.
-
Did BioLineRx Ltd. beat their earnings estimates last quarter?
In the previous quarter, BioLineRx Ltd. (:BLRX) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.14 by $0.15.
-
How can I listen to BioLineRx Ltd.'s earnings conference call?
The conference call for BioLineRx Ltd.'s latest earnings report can be listened to online.
-
How can I read BioLineRx Ltd.'s conference call transcript?
The conference call transcript for BioLineRx Ltd.'s latest earnings report can be read online.
-
How much revenue does BioLineRx Ltd. generate each year?
BioLineRx Ltd. (:BLRX) has a recorded annual revenue of $4.80 M.
-
How much profit does BioLineRx Ltd. generate each year?
BioLineRx Ltd. (:BLRX) has a recorded net income of $4.80 M. BioLineRx Ltd. has generated $-0.94 earnings per share over the last four quarters.
-
What is BioLineRx Ltd.'s price-to-earnings ratio?
BioLineRx Ltd. (:BLRX) has a price-to-earnings ratio of -1.13 and price/earnings-to-growth ratio is -0.03.
